Joseph A. Pierro
Technik-/Wissenschafts-/F&E-Leiter bei BioMedical Systems Corp.
Profil
Dr. Joseph A.
Pierro, MD, is Independent Director at FluoroPharma Medical, Inc. and Chief Medical Officer at BioMedical Systems Corp.
He is on the Board of Directors at FluoroPharma Medical, Inc.
He received his undergraduate degree from Canisius College and a doctorate degree from New York University.
Aktive Positionen von Joseph A. Pierro
| Unternehmen | Position | Beginn |
|---|---|---|
BioMedical Systems Corp.
 BioMedical Systems Corp. Medical/Nursing ServicesHealth Services BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2012 |
Ehemalige bekannte Positionen von Joseph A. Pierro
| Unternehmen | Position | Ende |
|---|---|---|
| FLUOROPHARMA MEDICAL, INC. | Direktor/Vorstandsmitglied | 12.11.2015 |
Ausbildung von Joseph A. Pierro
| New York University | Doctorate Degree |
| Canisius College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FLUOROPHARMA MEDICAL, INC. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
BioMedical Systems Corp.
BioMedical Systems Corp. Medical/Nursing ServicesHealth Services BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO. | Health Services |
